Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema
Clinical trial NCT02245516 · COMPLETED
Trial details
- NCT number
- NCT02245516
- Sponsor
- Kala Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2014-12-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.